Tolorio, Daylinda .
HRN: 23-95-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/25/2023
11/08/2023
IV
500mg
Every 8 Hours
Stab Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes